Document text
Principal Investigator: Silvia Miramontes Lizarraga
Organization: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Fiscal Year: 2024
Award: $44,892
Funding agency: National Institute on Aging
PROJECT SUMMARY
Uncovering factors influencing progression from Mild Cognitive Impairment (MCI) to Alzheimer’s Disease and
Alzheimer’s Disease Related Dementias (AD/ADRD) represents a valuable opportunity to prevent clinical
AD/ADRD and prolong functional independence of people along the AD/ADRD continuum. Identifying this
progression is particularly difficult due to the diverse clinical criteria used to diagnose MCI and extensive
underdiagnosis leaving a nebulous path for researchers attempting to learn from its phenotypic characteristics.
Leveraging informatics tools to identify MCI cases in Electronic Medical Records (EMR) offers a great
opportunity to mitigate the heterogeneity and underdiagnosis of MCI. Risk factors exacerbating the progression
from MCI to AD/ADRD have been previously studied in the context of clinical measures. However, few have
included neighborhood context measures as risk factors, which may be key to understanding the higher
AD/ADRD incidence rates among underrepresented populations. The objective of this F31 proposal is to equip
me with the necessary skills to pursue a career as an independent investigator using clinical data and other
large, complex information systems to identify opportunities to prevent and delay progression to AD/ADRD. To
achieve this goal, I will use longitudinal data from a large, diverse EMR system to identify MCI cases using
structured and unstructured data to evaluate whether neighborhood measures of resource availability and
indicators of cardiovascular risk factors predict time to progression from MCI to AD/ADRD. Aim 1 will identify
patients with MCI diagnosis via diagnostic codes and MCI early symptoms in clinical notes using EMR data
from the University of California, San Francisco (UCSF) through the construction of a specific natural language
processing (NLP) algorithm. This will be validated by comparing association with future AD/ADRD diagnosis
and ground-truth chart review on a selected sample. Aim 2 evaluates the independent and mediated effects of
neighborhood deprivation indices and cardiovascular disease (CVD) risk factors on time to progression from
MCI to AD/ADRD. Independent effects will be evaluated with time-varying-models of repeated measures of
CVD factors and neighborhood deprivation indices. Mediation will be used to determine whether place-level
deprivation effects are mediated by CVD risk burden on time to progression from MCI to AD/ADRD. The
proposed research contributes to the NIA goals to improve assessment of MCI and AD related conditions and
understand the effects of societal factors and health disparities on AD/ADRD. Under the guidance of a highly
qualified mentorship team, my training aims will augment my research aims by enhancing my understanding of
MCI and AD/ADRD clinical processes and phenotypes, provide training on causal inference methods using
longitudinal data with integration to machine learning models. With my highly committed mentorship team and
training environment at UCSF, I will succeed in my F31 proposed research, training plan, and acquire the skills
to emerge as an accomplished, independent clinical translational researcher in the field of AD/ADRD.
Terms: <AD dementia><AD related dementia><ADRD><Affect><Age><Algorithms><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's diagnosis><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease diagnosis><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Attention><Blood Pressure><California><Cardiovascular Diseases><Characteristics><Clinic><Clinical><Clinical Data><Clinical Informatics><Code><Coding System><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Complex><Computerized Medical Record><Data><Data Set><Data Sources><Data Systems><Dementia><Diagnosis><Diagnostic><Diagnostic Specificity><Disadvantaged><Disparity population><Disturbance in cognition><Drug Prescribing><Drug Prescriptions><EMR system><Electronic Medical Record><Environment><Ethnic Origin><Ethnicity><Evaluation><Exhibits><Future><Glycohemoglobin A><Glycosylated hemoglobin A><Goals><Hb A1><Hb A1a+b><Hb A1c><HbA1><HbA1c><Health><Hemoglobin A(1)><Heterogeneity><ICD Code><IT Systems><Impaired cognition><Incidence><Individual><Information Systems><Information Technology Systems><International Classification of Disease Codes><Investigators><Joints><Learning><Link><Machine Learning><Measures><Mediating><Mediation><Mentors><Mentorship><Methods><Modeling><Natural Language Processing><Negotiating><Negotiation><Neighborhoods><Out-patients><Outcome><Outpatients><Patients><Persons><Phase><Phenotype><Population><Population Heterogeneity><Predictive Factor><Primary Senile Degenerative Dementia><Process><QOL><Qualifying><Quality of life><Race><Races><Recruitment Activity><Research><Research Personnel><Research Proposals><Research Resources><Researchers><Resources><Risk Factors><SNOMED><Sampling><San Francisco><Selection Bias><Smoking><Societal Factors><Specialty><Structure><Symptoms><Systematized Nomenclature of Medicine><Time><Training><Underrepresented Groups><Underrepresented Populations><Universities><Validation><active recruitment><ages><cardiovascular disease risk><cardiovascular disorder><cardiovascular disorder risk><cardiovascular effects><cardiovascular risk><cardiovascular risk factor><career><clinical risk><clinical translation><clinically translatable><cognitive change><cognitive dysfunction><cognitive function><cognitive loss><cohort><community level disadvantage><dementia risk><deprivation><diagnostic criteria><disadvantaged community><disadvantaged group><disadvantaged individual><disadvantaged people><disadvantaged population><disadvantaged subgroup><disparities across groups><disparity across subgroups><disparity among groups><disparity among subgroups><disparity between groups><disparity between subgroups><disparity in health><diverse populations><electronic medical record system><electronic medical system><functional independence><group disparity><group inequality><group inequity><health disparity><hemoglobin A1c><heterogeneous population><improved><indexing><inequalities among populations><inequalities between populations><inequalities in populations><inequality across populations><inequality among groups><inequality between groups><inequality in groups><inequities among populations><inequities between populations><inequities in populations><inequity across groups><inequity across populations><inequity between groups><inequity in groups><informatics tool><machine based learning><machine learning based model><machine learning model><malleable risk><medical specialties><medication prescription><mild cognitive disorder><mild cognitive impairment><modifiable risk><natural language understanding><neighborhood barrier><neighborhood disadvantage><neighborhood-level barrier><neighborhood-level disadvantage><patient population><population diversity><population inequality><population inequity><prescribed medication><preservation><prevent><preventing><primary degenerative dementia><public health priorities><racial><racial background><racial diversity><racial origin><racially diverse><residence><residential building><residential site><risk factor for dementia><risk for dementia><senile dementia of the Alzheimer type><sex><skill acquisition><skill development><skills><social><social health determinants><socio-economic><socio-economically><socioeconomically><socioeconomics><structured data><subgroup disparity><support vector machine><translational investigator><translational researcher><translational scientist><under representation of groups><under represented groups><under represented people><under represented populations><underrepresentation of groups><underrepresented people><unequal group><unequal population><unstructured clinical data><unstructured data><validations><volunteer>